Ype Elgersma

33PUBLICATIONS
221CO-AUTHORS
Molecular targetsNonlinear optics and spectroscopyNeurology and neuromuscular diseasesMedical biochemistry - lipidsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Feb 25, 2026
Phosphoproteomic Analysis of Cortical Tissue from Mice Lacking Both CaMKIIα and CaMKIIβ Identifies Novel In Vivo Substrates.

Pomme M F Rigter, Karel Bezstarosti, Oguz Can Koc

|Feb 06, 2026
UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes.

Joseph C Krzeski, Edwin J Mientjes, Matthew C Judson

|Nov 26, 2025
Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Sébastien Küry, Janelle E Stanton, Geeske M van Woerden

|Aug 29, 2025
UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation.

Melanie Loix, Sam Vanherle, Laura Bolkaerts

|Aug 28, 2025
UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects.

Claudia Milazzo, Ramanathan Narayanan, Solveig Badillo

|Dec 12, 2024
CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.

Stine J Gauger, Maria E K Lie, Ilse Wallaard

Pageof 6